| Cited in | Search | Type: | Patent literature | Publication No.: | WO2013142525
[XI] (ALIOS BIOPHARMA INC et al.) [X] 1,2,4,6-12,14 * page 206; example 70; compounds 73-3, 73a * * page 255 - page 261; examples 111-117 * * claims 1-15, 86, 155, 212, 224 *[I] 1,2,4,6-12,14 | Type: | Patent literature | Publication No.: | EP2615101
[XI] (HIGH & NEW TECHNOLOGY RES CT HENAN ACADEMY OF SCIENCES et al.) [X] 1,2,4,6-12,14 * page 31; compounds 5-17 * * page 35; compounds 5-06, 5-07, 5-08 * * page 37; compounds 5-30, 5-31 * * page 39; compounds 5-07 * * page 40; compounds 5-17 * * claims 1,14 *[I] 1,2,4,6-12,14 | Type: | Non-patent literature | Publication information: | [XI] LAURENT F. BONNAC ET AL: "Structure-Activity Relationships and Design of Viral Mutagens and Application to Lethal Mutagenesis", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 23, 12 December 2013 (2013-12-12), pages 9403 - 9414, XP055270188, ISSN: 0022-2623, DOI: 10.1021/jm400653j [X] 1,2,4,6-12,14 * abstract * * page 9403 * * page 9404; table 1; compounds 3, 4 *[I] 1,2,4,6-12,14 | DOI: | http://dx.doi.org/10.1021/jm400653j | Type: | Non-patent literature | Publication information: | [XPI] OLIVER REYNARD ET AL: "Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication", VIRUSES, vol. 7, no. 12, 1 December 2015 (2015-12-01), pages 6233 - 6240, XP002783841, DOI: https://doi.org/10.3390/v7122934 [XP] 1,2,4,6-12,14 * page 6234; table 1; compound NHC *[I] 1,2,4,6-12,14 | DOI: | http://dx.doi.org/10.3390/v7122934 | Cited in | International search | Type: | Patent literature | Publication No.: | US2003087873
[XY] (STUYVER LIEVEN et al.) [X] 1-2, 14-18 * ; pg. 27, table 1: compound BS; para [0384], [0387] *[Y] 3, 10-13, 19-22 | Type: | Patent literature | Publication No.: | US2014235566
[XY] (AMBLARD FRANCK et al.) [X] 1, 4 * ; para [0036], [0173] *[Y] 5-9, 19, 22 | Type: | Patent literature | Publication No.: | US2004171860
[Y] (ZHAO HONG et al.) [Y] 5-7, 20-21 * ; para [0168] * | Type: | Patent literature | Publication No.: | US2014273023
[Y] (SALAMONE SALVATORE J et al.) [Y] 8 * ; pg. 9, Scheme 1 * | Type: | Patent literature | Publication No.: | WO2009143011
[Y] (NOVARTIS AG et al.) [Y] 10-11 * ; para [00116] * | Type: | Patent literature | Publication No.: | US5349947
[Y] (NEWHOUSE MICHAEL T et al.) [Y] 12-13 * ; col 5, para 3-4 * | Type: | Patent literature | Publication No.: | US2009105186
[A] (MATTHES ECKART et al.) [A] 1-22 * ; entire document * | Type: | Patent literature | Publication No.: | US5691319
[A] (KANEKO MASAKATSU et al.) [A] 1-22 * ; entire document * | Type: | Non-patent literature | Publication information: | [Y] DATABASE Pubchem 26 October 2006 (2006-10-26), XP055455213, Database accession no. 458 [Y] 3 * , compound * | Type: | Non-patent literature | Publication information: | [Y] DATABASE Pubchem 26 March 2005 (2005-03-26), XP055455220, Database accession no. 284 [Y] 9 * , compound * | Cited in | by applicant | Type: | Patent literature | Publication No.: | US2003087873
| Type: | Patent literature | Publication No.: | US2014235566
| Type: | Patent literature | Publication No.: | US2009105186
| Type: | Patent literature | Publication No.: | WO2013142525
| Type: | Patent literature | Publication No.: | EP2615101
| Type: | Patent literature | Publication No.: | US6372778
| Type: | Patent literature | Publication No.: | US6369086
| Type: | Patent literature | Publication No.: | US6369087
| Type: | Patent literature | Publication No.: | US6372733
| Type: | Non-patent literature | Publication information: | ROY ET AL.: "Pathogenesis of aerosolized Eastern equine encephalitis virus infection in guinea pigs", VIROL J, vol. 6, 2009, pages 170, XP021064278, DOI: 10.1186/1743-422X-6-170 | DOI: | http://dx.doi.org/10.1186/1743-422X-6-170 | Type: | Non-patent literature | Publication information: | STUYVER, ANTIMICROB AGENTS CHEMOTHER, vol. 47, no. 1, 2003, pages 244 - 54 | Type: | Non-patent literature | Publication information: | PUROHIT ET AL., J MED CHEM, vol. 55, no. 22, 2012, pages 9988 - 9997 | Type: | Non-patent literature | Publication information: | IVANOV ET AL., COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, vol. 71, no. 7, 2006, pages 1099 - 1106 | Type: | Non-patent literature | Publication information: | FOX ET AL., JACS, vol. 81, 1959, pages 178 - 87 | Type: | Non-patent literature | Publication information: | BONNAC ET AL.: "Structure-Activity Relationships and Design of Viral Mutagens and Application to Lethal Mutagenesis", J. MED CHEM, vol. 56, no. 23, 2013, pages 9403 - 9414, XP055270188, DOI: 10.1021/jm400653j | DOI: | http://dx.doi.org/10.1021/jm400653j | Type: | Non-patent literature | Publication information: | REYNARD ET AL.: "Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication", VIRUSES, vol. 7, no. 12, 2015, pages 6233 - 6240, XP002783841, DOI: 10.3390/v7122934 | DOI: | http://dx.doi.org/10.3390/v7122934 | Type: | Non-patent literature | Publication information: | STAHLWERMUTH: "Handbook of Pharmaceutical Salts: Properties, Selection, and Use", 2002, WILEY-VCH | Type: | Non-patent literature | Publication information: | TESTAMAYER: "Hydrolysis in Drug and Prodrug Metabolism", 2006, WILEY | Type: | Non-patent literature | Publication information: | "Remington's Pharmaceutical Sciences", 1989, MARCEL DEKKER, INC. | Type: | Non-patent literature | Publication information: | REMINGTON: "The science and practice of pharmacy", 2000, LIPPINCOTT WILLIAMS & WILKINS | Type: | Non-patent literature | Publication information: | ANSEL ET AL.: "Pharmaceutical dosage forms and drug delivery systems", 1995, WILLIAMS AND WILKINS | Type: | Non-patent literature | Publication information: | LAM, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 54, no. 8, 2010, pages 3187 - 3196 |